P/E ratio for HealthSouth (EHC)
P/E ratio as of April 2024 (TTM): 23.4
According to HealthSouth 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 23.3768. At the end of 2022 the company had a P/E ratio of 22.1.
P/E ratio history for HealthSouth from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 22.1 | 75.99% |
| 2021 | 12.5 | -45.29% |
| 2020 | 22.9 | 51.82% |
| 2019 | 15.1 | -8.65% |
| 2018 | 16.5 | 15.2% |
| 2017 | 14.3 | 21.12% |
| 2016 | 11.8 | -13.61% |
| 2015 | 13.7 | 9.78% |
| 2014 | 12.5 | 22.02% |
| 2013 | 10.2 | 2.38% |
| 2012 | 10.00 | 36.53% |
| 2011 | 7.32 | 366.16% |
| 2010 | 1.57 | -91.9% |
| 2009 | 19.4 | 509.42% |
| 2008 | 3.18 | 53.34% |
| 2007 | 2.08 | -192.4% |
| 2006 | -2.25 | -35.12% |
| 2005 | -3.46 | |
| 2002 | -3.44 | -85.39% |
| 2001 | -23.6 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Select Medical Holdings SEM | 17.1 | -26.69% | 🇺🇸 USA |
 HealthSouth
EHC | 23.4 | 0.00% | 🇺🇸 USA |
 Novo Integrated Sciences NVOS | -0.5316 | -102.27% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.